Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 16 | 2022 | 103 | 4.530 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 88 | 1.750 |
Why?
|
| Brain Ischemia | 2 | 2021 | 61 | 1.270 |
Why?
|
| Blood Pressure Determination | 2 | 2022 | 11 | 0.840 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2019 | 94 | 0.830 |
Why?
|
| Arterial Pressure | 1 | 2022 | 10 | 0.750 |
Why?
|
| Weather | 2 | 2019 | 13 | 0.740 |
Why?
|
| Subarachnoid Hemorrhage | 7 | 2019 | 38 | 0.730 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2022 | 858 | 0.720 |
Why?
|
| Hyperglycemia | 1 | 2020 | 27 | 0.670 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2020 | 4 | 0.660 |
Why?
|
| Blood Glucose | 1 | 2020 | 99 | 0.650 |
Why?
|
| Prospective Studies | 12 | 2021 | 1487 | 0.650 |
Why?
|
| Blood | 1 | 2019 | 17 | 0.630 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 111 | 0.620 |
Why?
|
| Neuroimaging | 1 | 2019 | 100 | 0.600 |
Why?
|
| Disease Progression | 2 | 2020 | 521 | 0.590 |
Why?
|
| Brain | 3 | 2021 | 1202 | 0.570 |
Why?
|
| Humans | 27 | 2022 | 22823 | 0.520 |
Why?
|
| Blood Pressure | 2 | 2022 | 166 | 0.510 |
Why?
|
| Middle Aged | 17 | 2020 | 7873 | 0.390 |
Why?
|
| Risk Factors | 7 | 2020 | 1966 | 0.360 |
Why?
|
| Male | 20 | 2020 | 12400 | 0.350 |
Why?
|
| Time Factors | 6 | 2020 | 1258 | 0.340 |
Why?
|
| Female | 20 | 2020 | 12904 | 0.340 |
Why?
|
| Atmospheric Pressure | 2 | 2019 | 8 | 0.300 |
Why?
|
| Aged | 14 | 2020 | 7412 | 0.290 |
Why?
|
| Vasospasm, Intracranial | 3 | 2019 | 9 | 0.260 |
Why?
|
| Incidence | 2 | 2019 | 624 | 0.250 |
Why?
|
| Hospital Mortality | 3 | 2015 | 129 | 0.230 |
Why?
|
| Adult | 9 | 2020 | 6896 | 0.230 |
Why?
|
| Cerebral Infarction | 3 | 2016 | 109 | 0.210 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 795 | 0.200 |
Why?
|
| Treatment Outcome | 5 | 2020 | 2934 | 0.200 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 438 | 0.190 |
Why?
|
| Radial Artery | 1 | 2022 | 6 | 0.190 |
Why?
|
| Brain Death | 2 | 2020 | 8 | 0.190 |
Why?
|
| Chicago | 3 | 2020 | 811 | 0.190 |
Why?
|
| Blindness | 1 | 2022 | 7 | 0.190 |
Why?
|
| Young Adult | 4 | 2020 | 1647 | 0.180 |
Why?
|
| Anticonvulsants | 2 | 2013 | 51 | 0.170 |
Why?
|
| Epilepsy | 2 | 2013 | 58 | 0.170 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 6 | 0.170 |
Why?
|
| Brain Edema | 1 | 2020 | 16 | 0.170 |
Why?
|
| Encephalocele | 1 | 2020 | 17 | 0.170 |
Why?
|
| Occupational Health | 1 | 2020 | 16 | 0.170 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 439 | 0.170 |
Why?
|
| Apnea | 1 | 2020 | 15 | 0.170 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 3717 | 0.170 |
Why?
|
| Hospitalization | 2 | 2020 | 285 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 63 | 0.160 |
Why?
|
| Prognosis | 2 | 2020 | 714 | 0.160 |
Why?
|
| Intracranial Thrombosis | 1 | 2019 | 6 | 0.160 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2019 | 9 | 0.160 |
Why?
|
| Endocarditis | 1 | 2019 | 10 | 0.160 |
Why?
|
| Blood Platelets | 2 | 2009 | 35 | 0.150 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 99 | 0.150 |
Why?
|
| Temperature | 1 | 2018 | 57 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 74 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 77 | 0.150 |
Why?
|
| Biomarkers | 1 | 2020 | 477 | 0.140 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1047 | 0.140 |
Why?
|
| Hypertension | 1 | 2018 | 163 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2020 | 2976 | 0.110 |
Why?
|
| Hematoma, Subdural | 1 | 2013 | 6 | 0.100 |
Why?
|
| Erythrocyte Transfusion | 2 | 2010 | 12 | 0.100 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2013 | 7 | 0.100 |
Why?
|
| Troponin I | 2 | 2013 | 11 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 57 | 0.100 |
Why?
|
| Community Health Centers | 1 | 2012 | 11 | 0.090 |
Why?
|
| Warfarin | 1 | 2012 | 25 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 29 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2012 | 82 | 0.090 |
Why?
|
| Critical Care | 2 | 2010 | 97 | 0.090 |
Why?
|
| Hemoglobins | 1 | 2010 | 26 | 0.080 |
Why?
|
| Anemia | 1 | 2010 | 30 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2010 | 12 | 0.080 |
Why?
|
| Blood Platelet Disorders | 1 | 2009 | 1 | 0.080 |
Why?
|
| Lateral Ventricles | 1 | 2009 | 4 | 0.080 |
Why?
|
| Phenytoin | 1 | 2009 | 5 | 0.080 |
Why?
|
| Comorbidity | 3 | 2020 | 426 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 252 | 0.080 |
Why?
|
| Blood Coagulation | 1 | 2009 | 20 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2009 | 18 | 0.080 |
Why?
|
| Euthanasia, Passive | 1 | 2009 | 1 | 0.080 |
Why?
|
| Life Support Care | 1 | 2009 | 4 | 0.080 |
Why?
|
| Disability Evaluation | 1 | 2010 | 218 | 0.070 |
Why?
|
| Age Factors | 2 | 2020 | 633 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2020 | 242 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2020 | 50 | 0.040 |
Why?
|
| Prevalence | 2 | 2013 | 375 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2019 | 14 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 27 | 0.040 |
Why?
|
| Syndrome | 1 | 2019 | 66 | 0.040 |
Why?
|
| Cerebral Angiography | 1 | 2019 | 29 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 64 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2009 | 38 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 158 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 268 | 0.040 |
Why?
|
| Aspirin | 2 | 2009 | 48 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 147 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 201 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 307 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 384 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 591 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2010 | 572 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2013 | 92 | 0.020 |
Why?
|
| Factor VIIa | 1 | 2012 | 8 | 0.020 |
Why?
|
| Plasma | 1 | 2012 | 13 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 17 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 546 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 523 | 0.020 |
Why?
|
| Registries | 1 | 2012 | 173 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2009 | 5 | 0.020 |
Why?
|
| Craniotomy | 1 | 2009 | 17 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 370 | 0.020 |
Why?
|
| Fever | 1 | 2009 | 32 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 2009 | 6 | 0.020 |
Why?
|
| Resuscitation Orders | 1 | 2009 | 3 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 121 | 0.020 |
Why?
|
| Death | 1 | 2009 | 39 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 294 | 0.020 |
Why?
|
| Acute Disease | 1 | 2009 | 162 | 0.020 |
Why?
|
| Cause of Death | 1 | 2009 | 54 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 216 | 0.020 |
Why?
|
| Myocardium | 1 | 2009 | 97 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 350 | 0.020 |
Why?
|
| Length of Stay | 1 | 2010 | 298 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 1412 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 1412 | 0.010 |
Why?
|